Jones Financial Companies
RCKT icon

Jones Financial Companies’s Rocket Pharmaceuticals RCKT Stock Holding History

Jones Financial Companies’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.99K Buy
2,765
+455
+20% +$1.51K ﹤0.01% 3841
2026
Q1 		$8.71K Buy
2,310
+325
+16% +$1.29K ﹤0.01% 3633
2025
Q4 		$6.97K Buy
1,985
+110
+6% +$377 ﹤0.01% 3379
2025
Q3 		$6.11K Sell
1,875
-150
-7% -$472 ﹤0.01% 3291
2025
Q2 		$5.12K Buy
2,025
+1,580
+355% +$8K ﹤0.01% 3125
2025
Q1 		$3.38K Hold
445
– – ﹤0.01% 3091
2024
Q4 		$5.59K Buy
445
+225
+102% +$3.39K ﹤0.01% 2720
2024
Q3 		$4.06K Hold
220
– – ﹤0.01% 2500
2024
Q2 		$4.74K Buy
+220
New +$5.05K ﹤0.01% 1947

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Jones Financial Companies's RCKT Position: Q2 2026 in Review

Jones Financial Companies increased its Rocket Pharmaceuticals (RCKT) stake by 20% in Q2 2026, buying an estimated $1.51K and bringing the position to 2,765 shares worth $8.99K. The position accounts for ﹤0.01% of the portfolio, ranked #3841.

Jones Financial Companies first reported a position in RCKT in Q2 2024 and has held it in 9 quarters since. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Jones Financial Companies held 2,765 shares of Rocket Pharmaceuticals worth $8.99K as of Q2 2026.
  • Jones Financial Companies bought 455 Rocket Pharmaceuticals shares in Q2 2026, an estimated $1.51K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3841 holding.
  • Jones Financial Companies first reported a position in Rocket Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.